Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV–HIV International Panel
- 31 May 2007
- journal article
- review article
- Published by Wolters Kluwer Health in AIDS
- Vol. 21 (9), 1073-1089
- https://doi.org/10.1097/qad.0b013e3281084e4d
Abstract
No abstract availableThis publication has 183 references indexed in Scilit:
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionHepatology, 2006
- 744 Sustained virologic response (SVR) to interferon-alpha-2b +/- ribavirin therapy at 6 months reliably predicts long-term clearance of HCV at 5-year follow-upJournal of Hepatology, 2006
- 738 A one year randomized, placebo-controlled, double-blind trial of rosiglitazone in non-alcoholic steatohepatitis: Results of the flirt pilot trialJournal of Hepatology, 2006
- 734 Peginterferon alpha-2a (PEGASYS) plus ribavirin (COPEGUS) for 16 or 24 weeks in patients with HCV genotype 2 OR 3. Final results of the accelerate trialJournal of Hepatology, 2006
- Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: The SHASTA indexJournal of Hepatology, 2005
- SHORT STATEMENT OF THE FIRST EUROPEAN CONSENSUS CONFERENCE ON THE TREATMENT OF CHRONIC HEPATITIS B AND C IN HIV CO-INFECTED PATIENTSJournal of Hepatology, 2005
- Towards more individualised management of hepatitis C virus patients with initially or persistently normal alanineaminotransferase levelsJournal of Hepatology, 2005
- Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patientsJournal of Hepatology, 2004
- Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis CHepatology, 2004
- Progression of Chronic Hepatitis C to Liver Fibrosis and Cirrhosis in Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency VirusClinical Infectious Diseases, 2003